AbbVie
Yinuo Pang is an accomplished pharmaceutical scientist with extensive experience in clinical pharmacology and drug development. Currently serving as Senior Director and Head of Solid Tumor in Clinical Pharmacology at AbbVie since May 2017, Yinuo previously held roles including Senior Research Fellow and Director of Clinical Pharmacology & Pharmacometrics. Prior to AbbVie, Yinuo was a PK/PD Expert at Novartis from September 2009 to May 2017 and worked at Schering-Plough Biopharma from September 2005 to August 2009 as an Associate Principle Scientist and Senior Scientist. Yinuo began a career in research at ICOS as an Associate Staff Scientist. Academic credentials include a Ph.D. in Pharmaceutical Sciences from Virginia Commonwealth University and an M.S. in Pharmaceutical Sciences from Sichuan University.
This person is not in any teams
This person is not in any offices
AbbVie
253 followers
AbbVie is a pharmaceutical company that discovers, develops, and markets both biopharmaceuticals and small molecule drugs.